Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Major depression

Recruiting

InvestigationalNo placebo

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

InvestigationalNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE

Contact Research Centre

General anaesthesia+1

Recruiting

Registered drugNo placebo

Comparison of remifentanil and rocuronium for improving video laryngoscopy assisted tracheal intubation in adult patients undergoing general anesthesia

Registered drugNo placebo

Sweden

Participants:18–64 years
Substances:Rocuronium Bromide

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drug

Study of dupilumab injections to reduce airway inflammation in adults aged 40-85 with chronic obstructive pulmonary disease

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Dupilumab

Contact Research Centre

B-cell small lymphocytic lymphoma refractory+1

Recruiting

Registered drugNo placebo

Study of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Obinutuzumab

Contact Research Centre

Ovarian cancer

Recruiting

Registered drugNo placebo

Study of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Pancreatic carcinoma

Recruiting

Registered drugNo placebo

Evaluation of Hydrocortisone, Octreotide, and Teres Ligament Patch Combination to Prevent Complications After Pancreatoduodenectomy in Patients with Pancreatic Head Cancer or IPMN

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Hydrocortisone

Contact Research Centre

Endometrial cancer

Recruiting

Registered drugNo placebo

Study of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Endometrial cancer

Recruiting

Registered drugNo placebo

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Advanced or Recurrent Endometrial Cancer

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Myocardial ischaemia

Recruiting

Registered drugNo placebo

Study on the Effects of Different Doses of Adenosine for Patients with Chronic Coronary Syndrome, with and without Heart Failure

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Adenosine

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drug

Study of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Tezepelumab

Contact Research Centre

Malignant melanoma stage III

Recruiting

Registered drugNo placebo

Study Comparing Ipilimumab and Nivolumab to Nivolumab Alone for Patients with Resectable Stage III Melanoma

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drug

Study on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Find therapies in clinical trials near you – page 5

324 trials match your criteria

Major depression

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

General anaesthesia+1

Comparison of remifentanil and rocuronium for improving video laryngoscopy assisted tracheal intubation in adult patients undergoing general anesthesia

Chronic obstructive pulmonary disease

Study of dupilumab injections to reduce airway inflammation in adults aged 40-85 with chronic obstructive pulmonary disease

B-cell small lymphocytic lymphoma refractory+1

Study of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

Ovarian cancer

Study of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer

Pancreatic carcinoma

Evaluation of Hydrocortisone, Octreotide, and Teres Ligament Patch Combination to Prevent Complications After Pancreatoduodenectomy in Patients with Pancreatic Head Cancer or IPMN

Endometrial cancer

Study of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients

Endometrial cancer

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Advanced or Recurrent Endometrial Cancer

Myocardial ischaemia

Study on the Effects of Different Doses of Adenosine for Patients with Chronic Coronary Syndrome, with and without Heart Failure

Chronic obstructive pulmonary disease

Study of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Malignant melanoma stage III

Study Comparing Ipilimumab and Nivolumab to Nivolumab Alone for Patients with Resectable Stage III Melanoma

Acute myeloid leukaemia

Study on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.